Hydrocodone cough suppressants will be taken off the market.

  The FDA will be pulling some unapproved hydrocodone cough suppressants from the market.

  The withdrawal mostly concerns hydrocodone cough preps with guaifenesin (Hycotuss, etc) or with homatropine PLUS an expectorant or decongestant (Histinex, etc).

  These drugs came on the market before proof of efficacy and safety was required. Some of the unapproved products are also labeled for use in children as young as 2-years-old, even though hydrocodone cough suppressants have not been proven safe or effective for children under 6-years-old.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote